# MYQORZO
> **NDA219083** · New Drug Application · Sponsor: CYTOKINETICS · Approved 2025-12-19
## Drug
- **FDA Application Number:** NDA219083
- **Application type:** New Drug Application
- **Brand name:** MYQORZO
- **Generic name:** AFICAMTEN
- **Active ingredients:** AFICAMTEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CYTOKINETICS
- **Manufacturer:** Cytokinetics Inc.
- **First approval:** 2025-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219083)
---
*MORVS · CC0 1.0*